Skinny jab? Try skinny juice. For centuries, it’s been enjoyed by people in South America — and it’s long been linked to ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has found. The anti-obesity injections could reduce the risk in obese people ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Semaglutide — the active ingredient in Ozempic and Wegovy — is part of ... Last March, Wegovy was approved to reduce the risk of stroke, heart attacks and other serious cardiovascular problems ...

Ozempic (semaglutide ... These risks can include heart attack, stroke, and death due to heart or blood vessel issues. Lower the risk of kidney disease progression and heart-related death in ...

UK drug chiefs have approved the use of semaglutide, the main ingredient of Ozempic and Wegovy, to prevent heart attacks and strokes in patents who are overweight. The decision comes after ...

Ozempic (semaglutide ... diseases of the heart or blood vessels may take it to lower their chance of a heart attack or stroke. With little research on how GLP-1 drugs affect pregnancy, experts ...

Ozempic is also approved to reduce the risk of heart attack and stroke in adults with type 2 diabetes who also have heart disease. It’s not known whether Mounjaro is effective for this use.

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...